Omalizumab does not improve skin lesions in a patient with hypocomplementemic urticarial vasculitis syndrome.S Aurich, J C Simon, R Treudler
No abstract text is available yet for this article.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
You can now claim free CME credits for this literature searchClaim now